Biotech is coming back in favour as drug stock

Biotech stocks are coming back into favour within the pharmaceuticals sector, and it is the largest ...

Biotech stocks are coming back into favour within the pharmaceuticals sector, and it is the largest stocks that offer the higher security. Pharmaceuticals rely on a consistent output of new and lucrative products to replace those that lose their patent and become far less profitable. Antony Milford, manager of the Framlington health fund, thinks that, with some exceptions, there have been few such failures to come up with new products. But he believes pharmaceuticals will have a much harder time in the next five years and biotechs are well positioned to supplement the supply lines of the...